Specializations
Cancer Surgery
Pancreatic Surgery
Bile Duct Surgery
Bariatric Metabolic Surgery
Oncological Surgery
Breast Surgery
Gastric cancer
Colon cancer
Thyroid Cancer
Obesity Surgery
Diabetes Surgeries
Mehr lesen
Specializations
Cancer Surgery
Pancreatic Surgery
Bile Duct Surgery
Bariatric Metabolic Surgery
Oncological Surgery
Breast Surgery
Gastric cancer
Colon cancer
Thyroid Cancer
Obesity Surgery
Diabetes Surgeries
Einer der besten Krebsspezialisten in Europa, Pädagoge und Krebsforscher, Präsident der Central European Cooperative Oncology Group (CECOG).
Hat über 600 wissenschaftliche Arbeiten zur Krebsbehandlung veröffentlicht.
Einer der besten Krebsspezialisten in Europa, Pädagoge und Krebsforscher, Präsident der Central European Cooperative Oncology Group (CECOG).
Hat über 600 wissenschaftliche Arbeiten zur Krebsbehandlung veröffentlicht.
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr
Erfahrener Chirurg mit Expertise in den Bereichen Peritoneale Onkologie, Melanom- und Sarkomchirurgie, laparoskopische und robotergestützte Chirurgie sowie hepatobiliäre und pankreatische Chirurgie. Referent auf nationalen und internationalen Kongressen zur chirurgischen Behandlung fortgeschrittener Bauch- und Beckenkrebserkrankungen, Autor und Co-Autor wissenschaftlicher Veröffentlichungen von nationaler und internationaler Bedeutung und Prüfer klinischer Studien zur onkologischen Chirurgie von nationaler und internationaler Bedeutung. Mitglied nationaler und internationaler wissenschaftlicher Gemeinschaften.
Mehr lesenErfahrener Chirurg mit Expertise in den Bereichen Peritoneale Onkologie, Melanom- und Sarkomchirurgie, laparoskopische und robotergestützte Chirurgie sowie hepatobiliäre und pankreatische Chirurgie. Referent auf nationalen und internationalen Kongressen zur chirurgischen Behandlung fortgeschrittener Bauch- und Beckenkrebserkrankungen, Autor und Co-Autor wissenschaftlicher Veröffentlichungen von nationaler und internationaler Bedeutung und Prüfer klinischer Studien zur onkologischen Chirurgie von nationaler und internationaler Bedeutung. Mitglied nationaler und internationaler wissenschaftlicher Gemeinschaften.
Arztbesuch | preis auf anfrage |
Entfernung von Dickdarmkrebs | $38976.15 - $105792.41 |
Chemotherapie | $2784.01 - $3897.62 |
Prostatektomie |
Arztbesuch | preis auf anfrage |
Entfernung von Dickdarmkrebs | $38976.15 - $105792.41 |
Chemotherapie | $2784.01 - $3897.62 |
Prostatektomie |
Education and Specialization
2017 Istanbul University Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Internal Medicine
19 November 2020 Istanbul University Istanbul Faculty of Medicine, Department of Medical Oncology
2011-25 June 2015 Hospitals/ Istanbul Haydarpasa Numune Education and Research Hospital
2004 Mersin University Faculty of Medicine
Experience
13.11.2017-29.03.2021 Istanbul University Istanbul Faculty of Medicine Internal Medicine Departments, Department of Internal Medicine
21.03.2011-25.06.2015 Istanbul Haydarpasa Numune Education and Research Hospital
Ferhatoğlu Ferhat, Çağatay Tülin, Okumuş Nigar Gülfer, Aydıner Adnan, Paksoy Nail, Ak Naziye, Aydın Esra, Saip Pınar Mualla (2023). Laterality Of Adrenal Gland Metastasis İn Lung Cancer: Results Of A Comparative Study. Eurasian Journal Of Medical Investigatin, 7(2), 101-106., Doi: 10.14744/Ejmi.2023.58954
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
TAŞTEKİN DİDEM, PAKSOY NAİL, DOĞAN İZZET, FERHATOĞLU FERHAT, KHANMAMMADOV NIJAT, BOZBEY HAMZA UĞUR, KARABULUT SENEM (2023). Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first?line treatment of metastatic gastric cancer: A single?center experience. Journal of Cancer Research and Therapeutics, 19(2), 253-258., Doi: 10.4103/jcrt.jcrt_672_22 (Çeyreklik Dilim=Q4)
KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340
KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340
FERHATOĞLU FERHAT, AYDINER ADNAN, PAKSOY NAİL (2022). Evaluation of clinical features and risk factors related to late recurrence (>5 years) in patients with breast cancer. Journal of Surgery and Medicine, 6(12), 986-990., Doi: 10.28982/josam.7610
FERHATOĞLU FERHAT, ERTÜRK KAYHAN, TAŞ FARUK (2022). Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences. Journal of Cancer Research and Therapeutics, 0, Doi: 10.4103/jcrt.jcrt_815_21
ÖZGÜR EMRE, FERHATOĞLU FERHAT, ŞEN FATMA, GEZER UĞUR (2022). Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer. BALKAN MEDICAL JOURNAL, 39(6), 450-451., Doi: 10.4274/balkanmedj.galenos.2022.2022-5-18
Makaleler
TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates. JOURNAL OF COSMETIC DERMATOLOGY, 21(4), 1570-1573., Doi: 10.1111/jocd.14278
TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Completion Lymph Node Dissection Is Unnecessary After Positive Sentinel Lymph Node in Melanoma — a Case Series Analysis. Indian Journal of Surgery, Doi: 10.1007/s12262-022-03532-y
DOĞAN İZZET, GÜRBÜZ MUSTAFA, PAKSOY NAİL, FERHATOĞLU FERHAT, VATANSEVER SEZAİ, SAİP PINAR, DEMİRKAZIK AHMET, AYDINER ADNAN (2022). Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. Medicine, 101(34), 30188, Doi: 10.1097/MD.0000000000030188
PAKSOY NAİL, KHANMAMMADOV NIJAT, DOĞAN İZZET, FERHATOĞLU FERHAT, YILDIZ ANIL, AK NAZİYE, AYDINER ADNAN (2022). Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study. Medicine, 101(45), 31726, Doi: 10.1097/MD.0000000000031726
PAKSOY NAİL, FERHATOĞLU FERHAT, DOĞAN İZZET, KHANMAMMADOV NIJAT, İRİBAŞ ÇELİK AYÇA, GÜLBAŞ ZAFER, BAŞARAN MERT (2022). High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience. Medicine, 101(49), 32213, Doi: 10.1097/MD.0000000000032213
ÇİL İBRAHİM, KÜÇÜKARDA AHMET, ATCI MUHAMMED MUSTAFA, SECMELER SABAN, PAKSOY NAİL, FERHATOĞLU FERHAT, AK NAZİYE, AYHAN MURAT, TATAROĞLU ÖZYÜKSELER DENİZ, ÖNDER ARİF HAKAN, AVCI OKAN, OYMAN ABDİLKERİM, OKTEN ILKER NİHAT, GÜLTÜRK İLKAY, AKAGÜNDÜZ BARAN, BAŞOĞLU TÜYLÜ TUĞBA, ÇAKIR EMRE, HACIBEKİROĞLU İLHAN, ÖZÇELİK MELİKE, AYDINER ADNAN (2022). Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori Journal, 108(1), 19-25., Doi: 10.1177/03008916211037739
DOĞAN İZZET, KARABULUT SENEM, TAŞTEKİN DİDEM, FERHATOĞLU FERHAT, PAKSOY NAİL, ŞAKAR BURAK (2022). Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer. Journal of the College of Physicians and Surgeons Pakistan, 32(8), 1014-1019., Doi: 10.29271/jcpsp.2022.08.1014
FERHATOĞLU FERHAT, TUĞCU MURAT, APAYDIN SÜHEYLA (2022). Factors Affecting Postoperative Morbidity and Mortality in Chronic Hemodialysis Patients. Eurasian Journal of Medical Advances, 2(3), 30-38., Doi: 10.14744/ejma.2022.43153
KAPAĞAN TANJU, FERHATOĞLU FERHAT, EMEKLİ SELİNAY, KILIÇ ÇAĞLA ECEM (2022). Risk Factors for Cutaneous Melanomas and Level of Awareness in Society. Journal of the Turkish Academy of Dermatology, 16(4), 94-100., Doi: 10.4274/jtad.galenos.2022.30092
FERHATOĞLU FERHAT, ALTAN FERHATOĞLU ZEYNEP (2022). Frequency, Demographic and Clinicopathological Characteristics of Skin Cancer Patients Treated and Followed Up in the Medical Oncology Outpatient Clinic. Journal of the Turkish Academy of Dermatology, 16(4), 77-81., Doi: 10.4274/jtad.galenos.2022.04706
KARABULUT SENEM, DOĞAN İZZET, USUL AFŞAR ÇİĞDEM, KARABULUT MEHMET, KARAMAN ŞULE, FERHATOĞLU FERHAT, TAŞTEKİN DİDEM (2021). Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 27(6), 1357- 1363., Doi: 10.1177/1078155220959427
AK NAZİYE, ÖZKAN BERKER, YENİGÜN BÜLENT MUSTAFA, YILMAZBAYHAN EMİNE DİLEK, TOKER SEYFİ ALPER, FERHATOĞLU FERHAT, YAŞAR HATİME ARZU, DİZBAY SAK SERPİL, TANJU SERHAT, DİLEGE MUSTAFA ŞÜKRÜ, ERUS SUAT, BULUTAY PINAR, FIRAT PINAR, MANDEL NİL MOLİNAS, KILIÇKAP SAADETTİN, ONDER SEVGEN, DİKMEN ERKAN, ALAN ÖZKAN, YUMUK PERRAN FULDEN, BOZKURTLAR EMİNE, LAÇİN TUNÇ, YILDIZELİ BEDRETTİN, ÖZTÜRK AKIN, KOCATÜRK CELALETTİN İBRAHİM, KARAPINAR KEMAL, ÜRER HALİDE NUR, OYAN ULUÇ BAŞAK, AYDINER ADNAN, DEMİRKAZIK AHMET, ERALP YEŞİM (2021). The role of adjuvant chemotherapy in resected stage I non – small cell lung cancer: A Turkish Oncology Group Study.. Journal of BUON, 26(3), 819-829.
AK NAZİYE, TOKER SEYFİ ALPER, KARA MURAT, ÖZKAN BERKER, ÜLKER MELİKE GÜLER, KABA ERKAN, YEGEN GÜLÇİN, KARAMAN ŞULE, DAĞOĞLU SAKİN RABİA NERGİZ, KAYTAN SAĞLAM ESRA, ORAL ETHEM NEZİH, KİZİR AHMET, BAYRAKTAR SOLEY, DİŞÇİ RİAN, FERHATOĞLU FERHAT, AYDIN ESRA, VATANSEVER SEZAİ, ERALP YEŞİM, AYDINER ADNAN (2021). Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center. TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 29(4), 487- 495., Doi: 10.5606/tgkdc.dergisi.2021.20529
AK NAZİYE, PAKSOY NAİL, FERHATOĞLU FERHAT, AYDIN ESRA, DOĞAN İZZET, BEKTAŞ ERDEM, KARACA MERT, OĞUZ SOYDİNÇ HİLAL, MİNARECİ YAĞMUR, SÖZEN HAMDULLAH, TOPUZ SAMET, SAİP PINAR MUALLA, VATANSEVER SEZAİ (2021). Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma. TURKISH JOURNAL of ONCOLOGY, 36(4), 438-445., Doi: 10.5505/tjo.2021.2882
Mehr lesenEducation and Specialization
2017 Istanbul University Istanbul Faculty of Medicine, Department of Internal Medicine, Department of Internal Medicine
19 November 2020 Istanbul University Istanbul Faculty of Medicine, Department of Medical Oncology
2011-25 June 2015 Hospitals/ Istanbul Haydarpasa Numune Education and Research Hospital
2004 Mersin University Faculty of Medicine
Experience
13.11.2017-29.03.2021 Istanbul University Istanbul Faculty of Medicine Internal Medicine Departments, Department of Internal Medicine
21.03.2011-25.06.2015 Istanbul Haydarpasa Numune Education and Research Hospital
Ferhatoğlu Ferhat, Çağatay Tülin, Okumuş Nigar Gülfer, Aydıner Adnan, Paksoy Nail, Ak Naziye, Aydın Esra, Saip Pınar Mualla (2023). Laterality Of Adrenal Gland Metastasis İn Lung Cancer: Results Of A Comparative Study. Eurasian Journal Of Medical Investigatin, 7(2), 101-106., Doi: 10.14744/Ejmi.2023.58954
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
FERHATOĞLU FERHAT, PAKSOY NAİL, BAŞARAN MERT (2022). Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center. Namık Kemal Medical Journal, 10(4), 350-356., Doi: 10.4274/nkmj.galenos.2022.78942
TAŞTEKİN DİDEM, PAKSOY NAİL, DOĞAN İZZET, FERHATOĞLU FERHAT, KHANMAMMADOV NIJAT, BOZBEY HAMZA UĞUR, KARABULUT SENEM (2023). Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first?line treatment of metastatic gastric cancer: A single?center experience. Journal of Cancer Research and Therapeutics, 19(2), 253-258., Doi: 10.4103/jcrt.jcrt_672_22 (Çeyreklik Dilim=Q4)
KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340
KAPAĞAN TANJU, FERHATOĞLU FERHAT (2023). Prognostic Factors for Intensive Care Unit (ICU) Admission among Hospitalized Gastrointestinal and Hepatopancreatobiliary Cancer Patients with Systemic Urinary Tract Infection. Eurasian Journal of Medical Investigation, 7(2), 107-115., Doi: 10.14744/ejmi.2023.81340
FERHATOĞLU FERHAT, AYDINER ADNAN, PAKSOY NAİL (2022). Evaluation of clinical features and risk factors related to late recurrence (>5 years) in patients with breast cancer. Journal of Surgery and Medicine, 6(12), 986-990., Doi: 10.28982/josam.7610
FERHATOĞLU FERHAT, ERTÜRK KAYHAN, TAŞ FARUK (2022). Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences. Journal of Cancer Research and Therapeutics, 0, Doi: 10.4103/jcrt.jcrt_815_21
ÖZGÜR EMRE, FERHATOĞLU FERHAT, ŞEN FATMA, GEZER UĞUR (2022). Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer. BALKAN MEDICAL JOURNAL, 39(6), 450-451., Doi: 10.4274/balkanmedj.galenos.2022.2022-5-18
Makaleler
TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates. JOURNAL OF COSMETIC DERMATOLOGY, 21(4), 1570-1573., Doi: 10.1111/jocd.14278
TAŞ FARUK, ERTÜRK KAYHAN, FERHATOĞLU FERHAT (2022). Completion Lymph Node Dissection Is Unnecessary After Positive Sentinel Lymph Node in Melanoma — a Case Series Analysis. Indian Journal of Surgery, Doi: 10.1007/s12262-022-03532-y
DOĞAN İZZET, GÜRBÜZ MUSTAFA, PAKSOY NAİL, FERHATOĞLU FERHAT, VATANSEVER SEZAİ, SAİP PINAR, DEMİRKAZIK AHMET, AYDINER ADNAN (2022). Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. Medicine, 101(34), 30188, Doi: 10.1097/MD.0000000000030188
PAKSOY NAİL, KHANMAMMADOV NIJAT, DOĞAN İZZET, FERHATOĞLU FERHAT, YILDIZ ANIL, AK NAZİYE, AYDINER ADNAN (2022). Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study. Medicine, 101(45), 31726, Doi: 10.1097/MD.0000000000031726
PAKSOY NAİL, FERHATOĞLU FERHAT, DOĞAN İZZET, KHANMAMMADOV NIJAT, İRİBAŞ ÇELİK AYÇA, GÜLBAŞ ZAFER, BAŞARAN MERT (2022). High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience. Medicine, 101(49), 32213, Doi: 10.1097/MD.0000000000032213
ÇİL İBRAHİM, KÜÇÜKARDA AHMET, ATCI MUHAMMED MUSTAFA, SECMELER SABAN, PAKSOY NAİL, FERHATOĞLU FERHAT, AK NAZİYE, AYHAN MURAT, TATAROĞLU ÖZYÜKSELER DENİZ, ÖNDER ARİF HAKAN, AVCI OKAN, OYMAN ABDİLKERİM, OKTEN ILKER NİHAT, GÜLTÜRK İLKAY, AKAGÜNDÜZ BARAN, BAŞOĞLU TÜYLÜ TUĞBA, ÇAKIR EMRE, HACIBEKİROĞLU İLHAN, ÖZÇELİK MELİKE, AYDINER ADNAN (2022). Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori Journal, 108(1), 19-25., Doi: 10.1177/03008916211037739
DOĞAN İZZET, KARABULUT SENEM, TAŞTEKİN DİDEM, FERHATOĞLU FERHAT, PAKSOY NAİL, ŞAKAR BURAK (2022). Evaluation of Prognostic Factors and Trastuzumab-based Treatments in HER2/Neu-positive Metastatic Gastric Cancer. Journal of the College of Physicians and Surgeons Pakistan, 32(8), 1014-1019., Doi: 10.29271/jcpsp.2022.08.1014
FERHATOĞLU FERHAT, TUĞCU MURAT, APAYDIN SÜHEYLA (2022). Factors Affecting Postoperative Morbidity and Mortality in Chronic Hemodialysis Patients. Eurasian Journal of Medical Advances, 2(3), 30-38., Doi: 10.14744/ejma.2022.43153
KAPAĞAN TANJU, FERHATOĞLU FERHAT, EMEKLİ SELİNAY, KILIÇ ÇAĞLA ECEM (2022). Risk Factors for Cutaneous Melanomas and Level of Awareness in Society. Journal of the Turkish Academy of Dermatology, 16(4), 94-100., Doi: 10.4274/jtad.galenos.2022.30092
FERHATOĞLU FERHAT, ALTAN FERHATOĞLU ZEYNEP (2022). Frequency, Demographic and Clinicopathological Characteristics of Skin Cancer Patients Treated and Followed Up in the Medical Oncology Outpatient Clinic. Journal of the Turkish Academy of Dermatology, 16(4), 77-81., Doi: 10.4274/jtad.galenos.2022.04706
KARABULUT SENEM, DOĞAN İZZET, USUL AFŞAR ÇİĞDEM, KARABULUT MEHMET, KARAMAN ŞULE, FERHATOĞLU FERHAT, TAŞTEKİN DİDEM (2021). Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 27(6), 1357- 1363., Doi: 10.1177/1078155220959427
AK NAZİYE, ÖZKAN BERKER, YENİGÜN BÜLENT MUSTAFA, YILMAZBAYHAN EMİNE DİLEK, TOKER SEYFİ ALPER, FERHATOĞLU FERHAT, YAŞAR HATİME ARZU, DİZBAY SAK SERPİL, TANJU SERHAT, DİLEGE MUSTAFA ŞÜKRÜ, ERUS SUAT, BULUTAY PINAR, FIRAT PINAR, MANDEL NİL MOLİNAS, KILIÇKAP SAADETTİN, ONDER SEVGEN, DİKMEN ERKAN, ALAN ÖZKAN, YUMUK PERRAN FULDEN, BOZKURTLAR EMİNE, LAÇİN TUNÇ, YILDIZELİ BEDRETTİN, ÖZTÜRK AKIN, KOCATÜRK CELALETTİN İBRAHİM, KARAPINAR KEMAL, ÜRER HALİDE NUR, OYAN ULUÇ BAŞAK, AYDINER ADNAN, DEMİRKAZIK AHMET, ERALP YEŞİM (2021). The role of adjuvant chemotherapy in resected stage I non – small cell lung cancer: A Turkish Oncology Group Study.. Journal of BUON, 26(3), 819-829.
AK NAZİYE, TOKER SEYFİ ALPER, KARA MURAT, ÖZKAN BERKER, ÜLKER MELİKE GÜLER, KABA ERKAN, YEGEN GÜLÇİN, KARAMAN ŞULE, DAĞOĞLU SAKİN RABİA NERGİZ, KAYTAN SAĞLAM ESRA, ORAL ETHEM NEZİH, KİZİR AHMET, BAYRAKTAR SOLEY, DİŞÇİ RİAN, FERHATOĞLU FERHAT, AYDIN ESRA, VATANSEVER SEZAİ, ERALP YEŞİM, AYDINER ADNAN (2021). Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center. TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 29(4), 487- 495., Doi: 10.5606/tgkdc.dergisi.2021.20529
AK NAZİYE, PAKSOY NAİL, FERHATOĞLU FERHAT, AYDIN ESRA, DOĞAN İZZET, BEKTAŞ ERDEM, KARACA MERT, OĞUZ SOYDİNÇ HİLAL, MİNARECİ YAĞMUR, SÖZEN HAMDULLAH, TOPUZ SAMET, SAİP PINAR MUALLA, VATANSEVER SEZAİ (2021). Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma. TURKISH JOURNAL of ONCOLOGY, 36(4), 438-445., Doi: 10.5505/tjo.2021.2882
Prof. Mustafa Özdemir ist Spezialist für Hautkrankheiten und kosmetische Dermatologie und Mitglied der Ärztekammer Istanbul, der türkischen Dermatologenvereinigung und der Vereinigung für Haut- und Geschlechtskrankheiten.
Mehr lesenProf. Mustafa Özdemir ist Spezialist für Hautkrankheiten und kosmetische Dermatologie und Mitglied der Ärztekammer Istanbul, der türkischen Dermatologenvereinigung und der Vereinigung für Haut- und Geschlechtskrankheiten.
Arztbesuch | preis auf anfrage |
Entfernung von Hirntumoren | $16000 - $17000 |
Schilddrüsenresektion | $4500 |
Prostatektomie | $9000 |
Hals-Nasen-Ohrenarzt. Facharzt für Kopf-Hals-Chirurgie.
Mehr lesenHals-Nasen-Ohrenarzt. Facharzt für Kopf-Hals-Chirurgie.
Arztbesuch | preis auf anfrage |
Entfernung von Hirntumoren | $16000 - $17000 |
Schilddrüsenresektion | $4500 |
Prostatektomie | $9000 |
Professor für Onkochirurgie und Proktologie
Mehr lesenProfessor für Onkochirurgie und Proktologie
Arztbesuch | preis auf anfrage |
Entfernung von Hirntumoren | $16000 - $17000 |
Schilddrüsenresektion | $4500 |
Prostatektomie | $9000 |
Endokrinologe
Mehr lesenEndokrinologe
Arztbesuch | preis auf anfrage |
Entfernung von Hirntumoren | $16000 - $17000 |
Schilddrüsenresektion | $4500 |
Prostatektomie | $9000 |
Arztbesuch | preis auf anfrage |
Entfernung von Dickdarmkrebs | $38976.15 - $105792.41 |
Chemotherapie | $2784.01 - $3897.62 |
Prostatektomie |
2022 - Halen, İstanbul/Türkiye
MEMORIAL BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2021 - 2022, İstanbul/Türkiye
MEDİCAL PARK BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2017 - 2021, İstanbul/Türkiye
İSTANBUL YENİ YÜZYIL ÜNİVERSİTESİ GAZİOSMANPAŞA HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2013 - 2017, Van/Türkiye
VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ TIP FAKÜLTESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2011 - 2013, Van /Türkiye
VAN EĞİTİM VE ARAŞTIRMA HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2004 - 2007, Ağrı /Türkiye
AĞRI PATNOS DEVLET HASTANESİ
İç Hastalıkları Uzmanı
Mehr lesen2022 - Halen, İstanbul/Türkiye
MEMORIAL BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2021 - 2022, İstanbul/Türkiye
MEDİCAL PARK BAHÇELİEVLER HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2017 - 2021, İstanbul/Türkiye
İSTANBUL YENİ YÜZYIL ÜNİVERSİTESİ GAZİOSMANPAŞA HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2013 - 2017, Van/Türkiye
VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ TIP FAKÜLTESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2011 - 2013, Van /Türkiye
VAN EĞİTİM VE ARAŞTIRMA HASTANESİ
İç Hastalıkları ve Tıbbi Onkoloji Uzmanı
2004 - 2007, Ağrı /Türkiye
AĞRI PATNOS DEVLET HASTANESİ
İç Hastalıkları Uzmanı
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Mehr lesenProfessional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Education:
Teaching course on “Lymphatic mapping and sentinel node”
June 1998, MDA Cancer Center, Houston, Texas, USA
General Surgery
Feb. 1993 – Dec. 1996, Şişli Etfal Hospital, Istanbul, Turkey
General Surgery
May 1990 – Jan. 1993, Lille University Hospital, Lille, France
M.D.
1983 – 1990, Cerrahpasa School of Medicine, Istanbul, Turkey
Experience
Attending General Surgeon, Jan. 1998 – present
F.N. Metropolitan Hospital, Istanbul, Turkey
American Cancer Center, Breast Surgery
Attending General Surgeon, 1996 – present
Medmar Diagnostic Center, Istanbul, Turkey
Diagnosis and monitoring with sophisticated techniques
General Surgeon, 1996 – 1998
Guzelbahce Medical Center and Yeditepe Hospital, Istanbul, Turkey
Specializing in breast and thyroid surgery
Mehr lesen
Education:
Teaching course on “Lymphatic mapping and sentinel node”
June 1998, MDA Cancer Center, Houston, Texas, USA
General Surgery
Feb. 1993 – Dec. 1996, Şişli Etfal Hospital, Istanbul, Turkey
General Surgery
May 1990 – Jan. 1993, Lille University Hospital, Lille, France
M.D.
1983 – 1990, Cerrahpasa School of Medicine, Istanbul, Turkey
Experience
Attending General Surgeon, Jan. 1998 – present
F.N. Metropolitan Hospital, Istanbul, Turkey
American Cancer Center, Breast Surgery
Attending General Surgeon, 1996 – present
Medmar Diagnostic Center, Istanbul, Turkey
Diagnosis and monitoring with sophisticated techniques
General Surgeon, 1996 – 1998
Guzelbahce Medical Center and Yeditepe Hospital, Istanbul, Turkey
Specializing in breast and thyroid surgery
Dr. Merdan Fayda ist Radioonkologe mit 19 Jahren Erfahrung in der Radioonkologie. Er hat an der Medizinischen Fakultät der Universität Istanbul und an der University of North Carolina (USA) Radiochirurgie studiert. Er führt 4D-Strahlentherapie, IMRT, MRT, CT und PET-CT durch. Er hat an 16 internationalen Konferenzen teilgenommen und ist Mitglied von 3 Organisationen.
Mehr lesenDr. Merdan Fayda ist Radioonkologe mit 19 Jahren Erfahrung in der Radioonkologie. Er hat an der Medizinischen Fakultät der Universität Istanbul und an der University of North Carolina (USA) Radiochirurgie studiert. Er führt 4D-Strahlentherapie, IMRT, MRT, CT und PET-CT durch. Er hat an 16 internationalen Konferenzen teilgenommen und ist Mitglied von 3 Organisationen.
Medical Field of Special Interest and Activities
Molecular Scanning
Nuclear Oncology
Radionuclide Treatments
Education and Experience
2018- Private LIV Hospital Ulus
2015-2018 İstanbul Bilim University, Şişli Florence Nightingale Hospital
2006-2015 Mersin University Master of Science in Nuclear Medicine
2005-2006 Ankara Özel Denge Medical Centre
2004 Hacettepe University Medical Faculty
Specialization Training: 2000-2004 Hacettepe University Master of Science in Nuclear Medicine
Undergraduate: 1993-1999 Hacettepe University Medical Faculty
Memberships
Journal of Musculoskeletal Pain
Turkish Journal of Clinical Sciences
Molecular Imaging and Radionuclide Therapy
Turkish Clinics Journal of Case Reports
Journal of Clinical and Experimental Investigations
Journal of Clinical and Analytical Medicine
Acıbadem University Health Sciences Magazine
Turkey Nuclear Medicine Association
Mehr lesenMedical Field of Special Interest and Activities
Molecular Scanning
Nuclear Oncology
Radionuclide Treatments
Education and Experience
2018- Private LIV Hospital Ulus
2015-2018 İstanbul Bilim University, Şişli Florence Nightingale Hospital
2006-2015 Mersin University Master of Science in Nuclear Medicine
2005-2006 Ankara Özel Denge Medical Centre
2004 Hacettepe University Medical Faculty
Specialization Training: 2000-2004 Hacettepe University Master of Science in Nuclear Medicine
Undergraduate: 1993-1999 Hacettepe University Medical Faculty
Memberships
Journal of Musculoskeletal Pain
Turkish Journal of Clinical Sciences
Molecular Imaging and Radionuclide Therapy
Turkish Clinics Journal of Case Reports
Journal of Clinical and Experimental Investigations
Journal of Clinical and Analytical Medicine
Acıbadem University Health Sciences Magazine
Turkey Nuclear Medicine Association
Dr. Dror Levin ist leitender Kinderarzt und Direktor der Behandlungsabteilungen für Blutkrankheiten und Knochenkrebs (Sarkom) im Kinderkrankenhaus „Dana“ bzw. im medizinischen Zentrum „Sourasky“. Er ist Facharzt für Kindermedizin, Hämatologie und Onkologie und hat zusätzliche Auslandserfahrung am Orthopädischen Institut Rizzoli in Italien.
Mehr lesenDr. Dror Levin ist leitender Kinderarzt und Direktor der Behandlungsabteilungen für Blutkrankheiten und Knochenkrebs (Sarkom) im Kinderkrankenhaus „Dana“ bzw. im medizinischen Zentrum „Sourasky“. Er ist Facharzt für Kindermedizin, Hämatologie und Onkologie und hat zusätzliche Auslandserfahrung am Orthopädischen Institut Rizzoli in Italien.